GlassScriptPhysician profile
Robert Lafitte Eller
NPI 1164482683
$1,006.63
in general payments reported to CMS, 2019-2025
15 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $156 · 2021: $105 · 2023: $92.25 · 2024: $44.09 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $239.34 | 2020-2025 | |
| Olympus America INC. | $219.48 | 2019-2025 | Diego Elite, Rhino-Laryngo Videoscope |
| Stryker Corporation | $131.48 | 2021-2025 | Ezout, Scopis Ent |
| Glaxosmithkline, LLC. | $125.37 | 2023-2025 | Nucala |
| Merck Sharp & Dohme LLC | $54.03 | 2024-2025 | Bridion, Keytruda |
| Integra Lifesciences Corporation | $50.47 | 2019 | |
| Acclarent, INC | $42.21 | 2021 | |
| Bard Access Systems, INC. | $25.85 | 2019 | |
| Optinose US, INC. | $22.21 | 2021 | |
| Ambu INC. | $20.91 | 2020 | |
| Alk-Abello, INC | $17.23 | 2021 | |
| Precigen, INC. | $15.87 | 2025 | |
| Pentax of America, INC. | $15.75 | 2020 | |
| Allergan, INC. | $13.36 | 2019 | |
| Smith+Nephew, INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Eller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.